FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma

Press Release
Written By Lindsey Settles

Read More

Lindsey Settles
Previous

Winners Announced: The Innovation Awards - D Magazine

Next

Wine Connoisseurs Say These Histamine-Reducing Wands Prevent Hangovers